Following to the previous information on Dec. 9th. in 2024, we are excited to share our latest development status. Regarding the Phase I/II clinical trial of DFP-10917 in combination with ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Inovio Pharmaceuticals has a twelve month low of $1.74 and a twelve month high of $14.75. The business has a 50 day simple moving average of $2.03 and a 200-day simple moving average of $4.15 ...

Japanese drugmaker Eisai Inc. will lay off 57 employees in Nutley between the end of March and May, public records show, as the pharmaceutical company shaves off 7% of its U.S. workforce.

Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. The biotech focused on low-dose results from its latest phase 2 trial, rather than the overall ...

Wie WESER-KURIER-Fotograf Ingo Möllers den Nachmittag mit seiner Kamera erlebt hat.

What’s the base and worst case scenarios in the event of the tariff hike on pharmaceuticals by the US? (Image Credits: Pixabay) While US President Donald Trump announced the likely imposition of ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79% The IRA, however, presents a different challenge. Merck has already had two drugs picked for the yearly list of ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

The FDA said it has also taken action against local entities involved with Aveo Pharmaceuticals. Samos Pharma, a registered importer, has been directed to cease collaborations with Aveo ...